loadpatents
Patent applications and USPTO patent grants for Dean; David Kenneth.The latest application filed is for "macrocyclic inhibitors of flaviviridae viruses".
Patent | Date |
---|---|
Macrocyclic inhibitors of flaviviridae viruses Grant 10,472,392 - Aciro , et al. Nov | 2019-11-12 |
Macrocyclic inhibitors of flaviviridae viruses Grant 10,246,486 - Aciro , et al. | 2019-04-02 |
Macrocyclic inhibitors of flaviviridae viruses Grant RE47,334 - Aciro , et al. | 2019-04-02 |
Macrocyclic inhibitors of flaviviridae viruses Grant 9,873,716 - Aciro , et al. January 23, 2 | 2018-01-23 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20170190737 - Aciro; Caroline ;   et al. | 2017-07-06 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20170190734 - Aciro; Caroline ;   et al. | 2017-07-06 |
Macrocyclic inhibitors of Flaviviridae viruses Grant 9,642,889 - Aciro , et al. May 9, 2 | 2017-05-09 |
Macrocyclic inhibitors of flaviviridae viruses Grant 9,512,175 - Aciro , et al. December 6, 2 | 2016-12-06 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20160220633 - Aciro; Caroline ;   et al. | 2016-08-04 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20150361132 - Aciro; Caroline ;   et al. | 2015-12-17 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20150344521 - Aciro; Caroline ;   et al. | 2015-12-03 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20150274774 - Aciro; Caroline ;   et al. | 2015-10-01 |
Macrocyclic inhibitors of flaviviridae viruses Grant 9,145,441 - Aciro , et al. September 29, 2 | 2015-09-29 |
Macrocyclic inhibitors of flaviviridae viruses Grant 9,090,653 - Aciro , et al. July 28, 2 | 2015-07-28 |
Macrocyclic inhibitors of Flaviviridae viruses Grant 9,062,092 - Steadman , et al. June 23, 2 | 2015-06-23 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20140030221 - Aciro; Caroline ;   et al. | 2014-01-30 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20130344030 - Steadman; Victoria Alexandra ;   et al. | 2013-12-26 |
Macrocyclic Inhibitors Of Flaviviridae Viruses App 20130344029 - Aciro; Caroline ;   et al. | 2013-12-26 |
5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators Grant 8,513,248 - Dean , et al. August 20, 2 | 2013-08-20 |
5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine derivatives as P2X7 modulators Grant 8,501,946 - Dean , et al. August 6, 2 | 2013-08-06 |
5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine Derivatives As P2x7 Modulators App 20120172366 - Dean; David Kenneth ;   et al. | 2012-07-05 |
Benzazepine derivatives for the treatment of neurological disorders Grant 8,207,331 - Bamford , et al. June 26, 2 | 2012-06-26 |
5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS App 20120157436 - Dean; David Kenneth ;   et al. | 2012-06-21 |
Imidazolidine carboxamide derivatives as P2X7 modulators Grant 7,932,282 - Beswick , et al. April 26, 2 | 2011-04-26 |
4-benzoyl-1-substituted-piperazin-2-one Derivatives As P2x7 Modulators App 20100311749 - Chambers; Laura Jane ;   et al. | 2010-12-09 |
Benzazepine derivatives for the treatment of neurological disorders Grant 7,799,773 - Bamford , et al. September 21, 2 | 2010-09-21 |
Aryl And Heteroaryl Sulphonamides As Growth Hormone Secretagogue Receptor Agonists App 20100179168 - Blaney; Emma Louise ;   et al. | 2010-07-15 |
Benzazepine Derivatives For The Treatment of Neurological Disorders App 20100145040 - Bamford; Mark James ;   et al. | 2010-06-10 |
Imidazolidine Carboxamide Derivatives as P2X7 Modulators App 20100075968 - Beswick; Paul John ;   et al. | 2010-03-25 |
Pyrazole Derivatives as P2X7 Modulators App 20100056595 - Beswick; Paul John ;   et al. | 2010-03-04 |
N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration App 20090149524 - Beswick; Paul John ;   et al. | 2009-06-11 |
Benzazepine Derivatives For The Treatment Of Neurological Disorders App 20090105226 - BAMFORD; Mark James ;   et al. | 2009-04-23 |
Pyridine derivatives as Raf kinase inhibitors Grant 7,452,906 - Bamford , et al. November 18, 2 | 2008-11-18 |
Pyridylfurans and pyrroles as Raf kinase inhibitors Grant 7,446,106 - Dean , et al. November 4, 2 | 2008-11-04 |
Piperazine derivatives useful for the treatment of gastrointestinal disorders Grant 7,381,728 - Dean , et al. June 3, 2 | 2008-06-03 |
Pyridine substituted furan derivatives as Raf kinase inhibitors Grant 7,375,105 - Dean , et al. May 20, 2 | 2008-05-20 |
Imidazole-2-Carboxamide Derivatives as Raf Kinase Inhibitors App 20080108615 - Dean; David Kenneth ;   et al. | 2008-05-08 |
Benzazepine Derivatives For The Treatment Of Neurological Disorders App 20070299056 - Bamford; Mark James ;   et al. | 2007-12-27 |
Pyridylfurans and pyrroles as Raf kinase inhibitors Grant 7,297,694 - Dean , et al. November 20, 2 | 2007-11-20 |
Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors Grant 7,297,693 - Bamford , et al. November 20, 2 | 2007-11-20 |
Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders App 20070259877 - Dean; David Kenneth ;   et al. | 2007-11-08 |
Heterocycle-carboxamide Derivatives As Raf Kinase Inhibitors App 20070244123 - Dean; David Kenneth ;   et al. | 2007-10-18 |
Imidazole-2-carboxamide derivatives as Raf kinase inhibitors Grant 7,282,500 - Dean , et al. October 16, 2 | 2007-10-16 |
Imidazole Derivatives As Raf Kinase Inhibitors App 20070135433 - DEAN; David Kenneth ;   et al. | 2007-06-14 |
Imidazole derivatives as Raf kinase inhibitors Grant 7,199,137 - Dean , et al. April 3, 2 | 2007-04-03 |
Benzazepine derivatives as histamine h3 antagonists App 20070060566 - Bailey; Nicholas ;   et al. | 2007-03-15 |
Compounds App 20060293298 - Bamford; Mark James ;   et al. | 2006-12-28 |
4-(4-(Heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's App 20060205774 - Bamford; Mark James ;   et al. | 2006-09-14 |
Pleuromutilin derivatives with antimicrobial activity Grant 7,045,524 - Dean , et al. May 16, 2 | 2006-05-16 |
Compounds Grant 7,026,336 - Dean , et al. April 11, 2 | 2006-04-11 |
Pleuromutilin derivatives with antimicrobial activity App 20050143393 - Dean, David Kenneth ;   et al. | 2005-06-30 |
Pyridylfurans and pyrroles as raf kinase inhibitors App 20040254186 - Dean, David Kenneth ;   et al. | 2004-12-16 |
Pyridine substituted furan derivatives as raf kinase inhibitors App 20040248896 - Dean, David Kenneth ;   et al. | 2004-12-09 |
Pyridine derivatives as raf kinase inhibitors App 20040235843 - Bamford, Mark James ;   et al. | 2004-11-25 |
Nitrogen-containing heterocyclic compounds and their use as raf inhibitors App 20040209883 - Bamford, Mark James ;   et al. | 2004-10-21 |
Pyridylfurans and pyrroles as raf kinase inhibitors App 20040198730 - Dean, David Kenneth ;   et al. | 2004-10-07 |
Heterocycle-carboxamide derivatives as raf kinase inhibitors App 20040192689 - Dean, David Kenneth ;   et al. | 2004-09-30 |
Imidazole-2-carboxamide derivatives as raf kinase inhibitors App 20040127496 - Dean, David Kenneth ;   et al. | 2004-07-01 |
Imidazole derivatives as raf kinase inhibitors App 20040038964 - Dean, David Kenneth ;   et al. | 2004-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.